445 related articles for article (PubMed ID: 18385764)
1. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
[TBL] [Abstract][Full Text] [Related]
2. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
[TBL] [Abstract][Full Text] [Related]
3. Identification of domain boundaries within the N-termini of TAP1 and TAP2 and their importance in tapasin binding and tapasin-mediated increase in peptide loading of MHC class I.
Procko E; Raghuraman G; Wiley DC; Raghavan M; Gaudet R
Immunol Cell Biol; 2005 Oct; 83(5):475-82. PubMed ID: 16174096
[TBL] [Abstract][Full Text] [Related]
4. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing.
Hicklin DJ; Kageshita T; Ferrone S
Tissue Antigens; 1996 Jul; 48(1):38-46. PubMed ID: 8864173
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2).
Androlewicz MJ; Ortmann B; van Endert PM; Spies T; Cresswell P
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12716-20. PubMed ID: 7809108
[TBL] [Abstract][Full Text] [Related]
7. Biogenesis of functional antigenic peptide transporter TAP requires assembly of pre-existing TAP1 with newly synthesized TAP2.
Keusekotten K; Leonhardt RM; Ehses S; Knittler MR
J Biol Chem; 2006 Jun; 281(26):17545-51. PubMed ID: 16624807
[TBL] [Abstract][Full Text] [Related]
8. Exploring the minimal functional unit of the transporter associated with antigen processing.
Koch J; Guntrum R; Tampé R
FEBS Lett; 2005 Aug; 579(20):4413-6. PubMed ID: 16061226
[TBL] [Abstract][Full Text] [Related]
9. Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.
López-Albaitero A; Mailliard R; Hackman T; Andrade Filho PA; Wang X; Gooding W; Ferrone S; Kalinski P; Ferris RL
J Immunother; 2009 Jun; 32(5):465-73. PubMed ID: 19609238
[TBL] [Abstract][Full Text] [Related]
10. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
[TBL] [Abstract][Full Text] [Related]
11. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
Li S; Paulsson KM; Sjögren HO; Wang P
J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
[TBL] [Abstract][Full Text] [Related]
12. Use of chimeric proteins to investigate the role of transporter associated with antigen processing (TAP) structural domains in peptide binding and translocation.
Arora S; Lapinski PE; Raghavan M
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7241-6. PubMed ID: 11416206
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression.
Kageshita T; Hirai S; Ono T; Hicklin DJ; Ferrone S
Am J Pathol; 1999 Mar; 154(3):745-54. PubMed ID: 10079252
[TBL] [Abstract][Full Text] [Related]
14. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.
Seliger B; Ritz U; Abele R; Bock M; Tampé R; Sutter G; Drexler I; Huber C; Ferrone S
Cancer Res; 2001 Dec; 61(24):8647-50. PubMed ID: 11751378
[TBL] [Abstract][Full Text] [Related]
15. Membrane topology and dimerization of the two subunits of the transporter associated with antigen processing reveal a three-domain structure.
Vos JC; Spee P; Momburg F; Neefjes J
J Immunol; 1999 Dec; 163(12):6679-85. PubMed ID: 10586064
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
17. Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits.
Antoniou AN; Ford S; Pilley ES; Blake N; Powis SJ
Immunology; 2002 Jun; 106(2):182-9. PubMed ID: 12047747
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z; Blankenstein T; Ljunggren HG; Kiessling R
J Immunol; 1997 Oct; 159(7):3195-202. PubMed ID: 9317117
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
[TBL] [Abstract][Full Text] [Related]
20. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells.
Salcedo M; Momburg F; Hämmerling GJ; Ljunggren HG
J Immunol; 1994 Feb; 152(4):1702-8. PubMed ID: 8120379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
